肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

BRCA1和BRCA2: 1994年及以后

BRCA1 and BRCA2: 1994 and beyond

原文发布日期:2004-09-01

DOI: 10.1038/nrc1431

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

BRCA1和BRCA2: 1994年及以后

BRCA1 and BRCA2: 1994 and beyond

原文发布日期:2004-09-01

DOI: 10.1038/nrc1431

类型: Review Article

开放获取: 否

 

要点:

  1. In the ten years since the discovery of BRCA1 and BRCA2, genetic testing for breast and ovarian cancer susceptibility has become integrated into the practice of clinical oncology.
  2. Attempts to identify a third breast cancer susceptibility locus (BRCA3) have so far been unsuccessful. This is probably because no single gene can account for the remainder of families that show a high incidence of breast cancer that is not associated with BRCA1 or BRCA2.
  3. In general, the genes that have been identified as being associated with hereditary breast cancer (BRCA1, BRCA2, TP53, CHK2 and ATM) are involved in the maintenance of genomic integrity and DNA repair.
  4. The risk of developing cancer is not identical for all carriers of BRCA1 and BRCA2 mutations. Risk can be influenced by allelic heterogeneity, modifier genes, and environmental and hormonal cofactors.

 

要点翻译:

  1. 在BRCA1和BRCA2基因发现后的十年间,乳腺癌和卵巢癌易感性的基因检测已融入临床肿瘤学实践。
  2. 目前寻找第三个乳腺癌易感基因位点(BRCA3)的努力尚未成功。这很可能是因为没有单一基因能够解释那些显示高乳腺癌发病率、却与BRCA1或BRCA2无关的剩余家族病例。
  3. 总体而言,已确认与遗传性乳腺癌相关的基因(BRCA1、BRCA2、TP53、CHK2和ATM)均参与维持基因组完整性和DNA修复。
  4. 并非所有BRCA1和BRCA2突变携带者的患癌风险完全相同。风险可能受到等位基因异质性、修饰基因以及环境和激素协同因素的影响。

 

英文摘要:

The discovery of the first gene associated with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs. Much has been learned during the past decade about the genetic epidemiology of breast cancer, the ethnic distribution and clinical consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility. The ability to translate this knowledge into novel treatments, however, remains elusive.

摘要翻译: 

首个与遗传性乳腺癌相关基因BRCA1的发现,曾被寄予厚望能大幅增进我们对遗传性和散发性乳腺癌的认识,并带来治疗与预防上的突破。过去十年里,我们在乳腺癌的遗传流行病学、BRCA1和BRCA2突变的种族分布及临床后果,以及DNA修复在乳腺癌易感性中的核心作用等方面已收获颇丰;然而,如何将这些知识转化为新型治疗手段,依旧遥不可及。

原文链接:

BRCA1 and BRCA2: 1994 and beyond

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……